3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Thrombosis
1
Squamous Cell Carcinoma of Head and Neck
1
Sexuality
1
Sexual Dysfunction, Physiological
1
Salivary Gland Neoplasms
1
Radiation Injuries
1
Protein Metabolism
1
Pain
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Mucositis
1
Malnutrition
1
Hemorrhage
1
Glioblastoma
1
Erectile Dysfunction
1
Disease
1
Diabetes Insipidus
1
Interventions
Fentanyl
19
Analgesia
15
Acupuncture Therapy
13
Oxycodone
12
Zoledronic Acid
11
Surveys and Questionnaires
10
nabiximols
9
Therapeutics
9
Morphine
9
Acetaminophen
9
Psychiatric Rehabilitation
8
Ketamine
8
Hydromorphone
7
Lidocaine
6
Ibandronic Acid
6
Radiotherapy
5
Early Intervention, Educational
5
Bupivacaine
5
Analgesics, Opioid
5
Yoga
4
Transcutaneous Electric Nerve Stimulation
4
Therapeutic Touch
4
Ropivacaine
4
Music Therapy
4
Methadone
4
Massage
4
Aromatherapy
4
alvimopan
3
Tapentadol
3
Saline Solution
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Pain
×
Arginine
×
Clear all
NCT05293041
2025-03-06
ARG-01
Sahlgrenska University Hospital
Phase 4
Completed
248 enrolled